Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MLYCD | O95822 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
| ▸ | NAMPT | P43490 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15015782 | 0.94 | GAA (0.41) | MGAMGAASIMGAM2POLB | |
| SCHEMBL30364188 | 0.92 | GAA (0.39) | MGAMGAASIMGAM2POLB | |
| SCHEMBL16266538 | 0.92 | GAA (0.39) | MGAMGAASIMGAM2POLB | |
| SCHEMBL29381101 | 0.92 | GAA (0.39) | MGAMGAASIMGAM2POLB | |
| SCHEMBL15016394 | 0.92 | GAA (0.39) | MGAMGAASIMGAM2POLB | |
| SCHEMBL16210306 | 0.76 | ALDH1A1 (0.35) | POLBL3MBTL1MLYCDALDH1A1LMNA | |
| SCHEMBL16210777 | 0.74 | CA12 (0.45) | POLBALDH1A1HDAC1HDAC6 | |
| SCHEMBL15512679 | 0.74 | POLB (0.35) | POLBL3MBTL1MLYCDALDH1A1LMNA | |
| SCHEMBL18279565 | 0.74 | POLB (0.35) | POLBL3MBTL1MLYCDALDH1A1LMNA | |
| SCHEMBL18279563 | 0.74 | POLB (0.35) | POLBL3MBTL1MLYCDALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9796806-B2 | Dioxomolybdenum (VI) complex compounds as catalysts for polyurethane compositions | SIKA TECHNOLOGY AG (CH) | 2017-10-24 | — | — | US | disclosed |
| US-20160326296-A1 | DIOXOMOLYBDENUM (VI) COMPLEX COMPOUNDS AS CATALYSTS FOR POLYURETHANE COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2016-11-10 | — | — | US | disclosed |
| US-9422390-B2 | Dioxomolybdenum (VI) complex compounds as catalysts for polyurethane compositions | SIKA TECHNOLOGY AG (CH) | 2016-08-23 | — | — | US | disclosed |
| US-20140329966-A1 | DIOXOMOLYBDENUM (VI) COMPLEX COMPOUNDS AS CATALYSTS FOR POLYURETHANE COMPOSITIONS | SIKA TECHNOLOGY AG (CH) | 2014-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160326296-A1 | DIOXOMOLYBDENUM (VI) COMPLEX COMPOUNDS AS CATALYSTS FOR POLYURETHANE COMPOSITIONS | DUOX2, PUF60, DUOX1 | MGAM 970/4885GAA 2186/4885SI 3074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.